Rita Tavarozzi, MD
SCDU Ematologia, Azienda Ospedaliera SS Antonio e Biagio e C. Arrigo, Alessandria, Italy · Dipartimento Medicina Traslazionale, Università del Piemonte Orientale - S.C. Ematologia ed Infrastruttura Ricerca Formazione ed Innovazione, A.O. SS. Antonio e Biagio e C. Arrigo (Alessandria, Italy)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Rita Tavarozzi, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:54 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07767799 · Biological Analysis of MABs in NHL in a Translational Prospective Observational Study Within Italian Clinical PracticeFondazione Italiana Linfomi - ETS · not yet recruiting · B-Cell Non-Hodgkin Lymphoma (NHL) · study chair
- Ph2NCT07453095 · Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell TherapyFondazione Italiana Linfomi - ETS · recruiting · Mantle Cell Lymphoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.